The Exchange has sought clarification from JHS Svendgaard Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has asked JHS Svendgaard Laboratories to clarify discrepancies found in the financial results it filed in XBRL (a digital reporting format) for the quarter ended 30 September 2025. This query has been raised under SEBI's Listing Obligations and Disclosure Requirements Regulations. As of now, the company has not yet submitted its response. XBRL discrepancies typically refer to inconsistencies between the data filed in the structured digital format and the original financial statements.
This is a procedural clarification request and not a penalty or enforcement action. Investors should watch for the company's response, as unresolved discrepancies could lead to further action from the exchange, but there is no immediate impact on trading or shareholder value.